Endeavor

Cell Therapy Superior to Standard of Care for Multiple Myeloma

Phase 3 trial results show improved response rate and reduced risk of disease progression

Treatment Innovations in Rectal, Lung and Brain Cancers

New research shows benefit of de-escalating and targeting therapies to improve outcomes

Adding Inhibitor to Hormonal Therapy Reduces Risk of Breast Cancer Recurrence

Phase 3 trial results could be practice changing for both men and women

New Study Shows Promise for Difficult to Treat Brain Metastases

First in human trial is recruiting patients with leptomeningeal disease from triple- negative or HER2 positive breast cancers

The Truth About Clinical Studies: The Most Advanced Cancer Care at Moffitt Cancer Center

Learn more about some common misconceptions that prevent patients from joining clinical trials.

Hematologist Trains at Moffitt, Hoping to Benefit Armenians

Through a visiting physician program, a doctor is learning the intricacies of an allogeneic BMT procedure and care to help his home country

Improving Cancer Care for People with HIV

Moffitt’s HIV clinic reduces burdens for patients fighting for their health on two fronts

Mobile Monitoring: Making Cancer Care More Accessible

Moffitt researchers and clinicians are taking telehealth to the next level

Global Clinical Trial Explores New Combination Therapy for Metastatic Breast Cancer

The ongoing VIKTORIA-1 Phase 3 trial targets patients with hormone receptor positive, HER2 negative breast cancer